TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse
- 7 October 2004
- journal article
- Published by Springer Nature in Leukemia
- Vol. 18 (12) , 1971-1980
- https://doi.org/10.1038/sj.leu.2403505
Abstract
Using the multiplex PCR tubes of the BIOMED-2 Concerted Action, TCRB gene rearrangements were detected in 35% of childhood (n=161) and adult (n=172) precursor-B-ALL patients (V–(D)–J in 25%; D–J in 15%). The presence of TCRB rearrangements showed a significant relation with age (highest frequency of 46% between 5 and 10 years of age) and the presence of TEL-AML1 transcripts, and was associated with relatively high frequencies of IGK-Kde, TCRG, and V2-J rearrangements. In 62 out of 65 patients with Southern blot-detected V–(D)–J and/or D–J rearrangements, at least one TCRB gene rearrangement was detected by PCR. Based on combined Southern blot and PCR analysis, oligoclonal TCRB gene rearrangements were observed in only 12% of patients. Analysis of paired diagnosis and relapse samples (n=26) showed that 20 out of 24 (83%) V–(D)–J rearrangements and eight out of 14 (57%) D–J rearrangements remained stable. Using real-time quantitative PCR, a quantitative range 10-4 was obtained in 64% of TCRB gene rearrangements and in 86% of cases a sensitivity 10-4 was obtained. In conclusion, TCRB gene rearrangements occur in 35% of precursor-B-ALL patients and are relatively stable and sensitive PCR targets for detection of minimal residual disease, particularly if this concerns complete V–(D)–J rearrangements.Keywords
This publication has 54 references indexed in Scilit:
- Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual diseaseLeukemia, 2003
- Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALLLeukemia, 2002
- Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCRLeukemia, 2002
- Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemiaBest Practice & Research Clinical Haematology, 2002
- Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemiaBest Practice & Research Clinical Haematology, 2002
- Acute Lymphoblastic LeukemiaHematology-American Society Hematology Education Program, 2002
- Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemiaLeukemia, 2001
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998